CSIMarket Company Name, Ticker, Suppliers, else..
 
The Oncology Institute Inc   (NASDAQ: TOI)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 
Price: $2.3900 $0.01 0.420%
Day's High: $2.43 Week Perf: -9.81 %
Day's Low: $ 2.23 30 Day Perf: -21.9 %
Volume (M): 2,397 52 Wk High: $ 3.50
Volume (M$): $ 5,728 52 Wk Avg: $0.93
Open: $2.40 52 Wk Low: $0.13



 Market Capitalization (Millions $) 184
 Shares Outstanding (Millions) 77
 Employees 825
 Revenues (TTM) (Millions $) 403
 Net Income (TTM) (Millions $) -53
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 4

The Oncology Institute Inc
The Oncology Institute Inc. is a medical organization specializing in oncology, or the diagnosis and treatment of cancer. Their primary focus is on providing comprehensive and personalized care to cancer patients. They offer a range of services including cancer screenings, diagnostic tests, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and supportive care. The Oncology Institute Inc. has a team of highly trained and experienced oncologists, nurses, and other medical professionals who work together to provide the best possible care for their patients. They are dedicated to advancing cancer research, promoting education and awareness about cancer prevention and treatment, and improving the quality of life for cancer patients.


   Company Address: 18000 Studebaker Road, Suite 800 Cerritos 90703 CA
   Company Phone Number: 735-3226   Stock Exchange / Ticker: NASDAQ TOI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AON        0.48% 
BMY   -5.81%    
CAH        1.23% 
MCK   -1%    
MRK   -3.24%    
PFE   -2.32%    
• View Complete Report
   



Shares

The Oncology Institute Secures $16.5 Million Boost Amid Surge in Stakeholder Confidence and Industry Innovations,

Published Mon, Mar 24 2025 10:01 AM UTC

The Oncology Institute Paves the Way for Growth with $16.5 Million Private Placement Amid Changing Healthcare LandscapeThe Oncology Institute, Inc. (NASDAQ: TOI), recognized as one of the most extensive value-based community oncology groups in the United States, is marking a significant milestone in its growth trajectory with the announcement of a $16.5 million private place...
Product Service News

A New Era in Oncology Care Florida Blue?s Optimism Amidst Industry Challenges

Published Wed, Dec 18 2024 9:05 PM UTC

As cancer care remains a focal point in the American healthcare landscape, Florida Blue is making strides in enhancing oncology services for its members. Recently, the nonprofit health insurer announced a new initiative designed to improve patient outcomes, experiences, and overall quality of life by streamlining access to affordable and high-quality cancer care. This initia...
The Oncology Institute Inc

The Oncology Institute Inc sees impressive revenue growth in Q1 2024, but falls short of profitability

The Oncology Institute Inc (NASDAQ: TOI) is a prominent healthcare facilities company that specializes in providing value-based oncology practices. In its recent report for the first quarter of 2024, the company announced a significant surge in revenue, with a growth of 24.247% to $94.67 million compared to the corresponding quarter a year prior.
However, despite the positive revenue growth, The Oncology Institute Inc experienced a loss of $-0.22 per share during the first quarter. This represents a shortfall compared to the previous year, where the loss per share was $-0.05. Nevertheless, the company's revenue still increased by 10.349% from $85.79 million in the same period.
Management Changes

Jordan McInerney Joins The Oncology Institute as Chief Development Officer, Brings Expertise to Tackle Negative ROI and Propel Value-Based Specialty Care Models

Published Mon, Apr 8 2024 12:01 PM UTC


The Oncology Institute, Inc. has recently appointed Jordan McInerney as their Chief Development Officer. The move comes at a crucial time for the company, as it recorded a cumulative net loss of $-68 million during the 12 months ending in the fourth quarter of 2023. This has resulted in a negative return on investment (ROI) of -35.66%.
McInerney s appointment brings...
Partnership

Evolving Cancer Care: The Oncology Institute and Healthly Team Up to Extend Services Across Southern California

Published Thu, Apr 4 2024 12:00 PM UTC

CERRITOS, Calif., - April 04, 2024 The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) have chosen to join forces with Healthly, a burgeoning healthcare company, to redefine cancer care accessibility and experience for patients in Southern California. Healthly boasts over 180 primary care physicians, a comprehensive range of support services, and a core philosoph...






The Oncology Institute Inc's Segments
Patient services    50.83 % of total Revenue
Capitated revenue    16.76 % of total Revenue
FFS revenue    34.07 % of total Revenue
Dispensary revenue    47.21 % of total Revenue
Clinical research trials and other revenue    1.96 % of total Revenue
segments    100 % of total Revenue
Patient services segments    50.83 % of total Revenue
Dispensary segments    47.21 % of total Revenue
Clinical trials other segments    1.96 % of total Revenue

  The Oncology Institute Inc Outlook

On March 27 2024 the The Oncology Institute Inc provided following guidance

During the fourth quarter of 2023, The Oncology Institute Inc. (TOI) achieved strong financial results, showcasing its position as one of the leading value-based community oncology groups in the country. The company, listed on the NASDAQ under the ticker symbol TOI, reported its year-end financial results on March 27, 2024.

The Oncology Institute Inc. disclosed that it had generated impressive revenue figures for both the fourth quarter and the full year of 2023. The company's success can be attributed to its commitment to providing high-quality care to cancer patients while also adhering to value-based principles. TOI's financial performance underscores its dedication to delivering exceptional servic...





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com